Effect Of COVID-19 on Circulating Tumor Cells Market Growth Statistics & Regional Opportunities 2021
Global CirculatingTumor Cells Market is anticipated to grow significantly in the coming years owing to the increasing cancer cases. Circulating tumor cells circulate inside the body through blood stream. They comprise seeds that are responsible for the growth of additional tumors in different organs, which cause cancer. Hence, different tumor detection markers are developed for the early discovery of cancer.
The
growth of circulating tumor cells (CTC) market is influenced by increasing
mortality rate due to cancer, several types of genetic disorders, drastic
change in lifestyle, increase in smoking-causing disorders, and rise in
consumption of alcohol. Moreover, developments in bioengineering technologies,
biomedical imaging and rise in demand for preventive medications for different
types of cancers are also stimulating the market growth of circulating tumor
cells. However, the factors restraining the market growth comprise significant
cost of detection techniques, scarcity of specific biomarkers for the detection
of CTCs, reluctance in the adoption of new technologies, and other technical
limits.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/circulating-tumor-cells-ctc-market/request-sample
Increasing
focus of the market players for the introduction of companion diagnostics for
cancer and other disorders and increase in demand for research projects on
cancer are few trends in the circulating tumor cells industry. Circulating
tumor cells market is categorized on the basis of technology, application, and
geography. On the basis of technology, the market is divided into CTC
Detection, CTC Enrichment, and CTC Analysis. CTC enrichment segment is expected
to lead the market owing to high efficiency due to increased functionalities.
Based
on application, circulating tumor cells (CTC) industry is divided into tumorigenesis
research, cancer stem cell research, EMT biomarkers development, and others.EMT
biomarkers development segment is predicted to hold maximum share of the market
due to advancements in technology.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/circulating-tumor-cells-ctc-market
In
terms of end user, circulating tumor cells (CTC) market is bifurcated into
research & academic institutes, hospitals & clinics, and diagnostic
centers. Hospitals and clinics segment is expected to hold larger share of the
market due to increasing preference for efficient treatment offered at hospitals.
Geographically,
CTC industry is segmented as North America, Latin America, Europe, Asia
Pacific, and Middle East & Africa. North America, followed by Europe
accounted for the larger share of market due to large number of market players
and mature healthcare infrastructure. Asia-Pacific is also expected to grow
considerably in the coming years due to increasing investment and growing
technological advancements in the domain.
The
prominent players in circulating tumor cells industry include ApoCell, Advanced
Cell Diagnostics, Inc, ClearbridgeBiomedicsPte Ltd, Aviva Biosciences,
CynvenioBiosystems, Inc, BioceptInc, MiltenyiBiotec,Menarini Silicon
Biosystems, Qiagen and CreatvMicrotech Inc.
Comments
Post a Comment